Company Filing History:
1 out of 658 
1 out of 155 Years Active: 2011
Title: Innovator Eun-Mi Hur: Pioneering Cytoprotective Methods
Introduction: Eun-Mi Hur, an inventive researcher based in Pohang, South Korea, has made significant contributions to the fields of biomedicine and pharmaceutical sciences. With one notable patent to her name, she is pioneering methods aimed at protecting cells from damage, particularly focusing on apoptosis.
Latest Patents: Eun-Mi Hur holds a patent titled “Method of protecting cells against damage and pharmaceutical composition comprising leumorphin.” This innovative invention outlines a method for safeguarding cells against damage induced by apoptosis. It involves the administration of a therapeutic dose of leumorphin, known for its cytoprotective activity, along with a pharmaceutical composition that contains an effective amount of this compound.
Career Highlights: Throughout her career, Eun-Mi Hur has been associated with esteemed institutions, notably the Postech Academy-Industry Foundation and the Postech Foundation. These organizations have provided her with a platform to explore and enhance her research in the pharmaceutical domain.
Collaborations: Eun-Mi has collaborated with talented colleagues, including Byoung Dae Lee and SooMi Kim. Their efforts in scientific inquiry have likely played a role in advancing the research around cytoprotection and the practical applications of leumorphin.
Conclusion: Eun-Mi Hur stands out as a prominent inventor in the realm of cytoprotection, having developed innovative methods to combat cell damage. Her work not only enriches the field of pharmaceuticals but also holds the potential for substantial therapeutic applications. As she continues her research, her contributions are sure to impact the future of biomedical science significantly.